Last updated on February 2018

Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Brief description of study

To evaluate safety and efficacy of two dosing regimens in achieving clinical remission in subjects with moderately to severely active Ulcerative Colitis.

Clinical Study Identifier: NCT02065622

Contact Investigators or Research Sites near you

Start Over

AbbVie_Call Center

Susaki Kuroshio Hospital /ID# 125202
Susaki-shi, Japan
  Connect »